Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
269.90    -0.30 (-0.11%)
Bid:
270.60
Ask:
270.70
Spread: 0.10 (0.037%)
Market Cap: £14.81b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Transaction in Own Shares

17 Jun 2024 18:15

RNS Number : 7718S
Legal & General Group Plc
17 June 2024
 

LEGAL AND GENERAL GROUP PLCISIN: GB000560399717th June 2024

 

LEI number: 213800JH9QQWHLO99821

 

LEGAL AND GENERAL GROUP PLC (the "Company")Transaction in Own Shares

The Company announces that on 17th June 2024 it had purchased a total of 1,000,000 of its ordinary shares of 2.5 pence each (the "ordinary shares"), through the Company's broker Barclays Capital Securities Limited as detailed below. The repurchased ordinary shares will be cancelled.

London Stock Exchange

CBOE BXE

Turquoise Services Limited

Aquis Limited

Cboe Europe Limited

Number of ordinary shares purchased

391,874

161,919

153,467

106,341

186,399

Highest price paid

(per ordinary share)

229.20

229.20

229.10

229.10

229.20

Lowest price paid

(per ordinary share)

226.70

226.70

226.70

226.70

226.70

Average price paid

(per ordinary share)

228.35

228.16

228.22

228.25

228.28

The purchases form part of the Company's share buyback programme announced on 12 June 2024.

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 5,977,391,177 ordinary shares.

No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 5,977,391,177.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as incorporated into and implemented under English law (including by virtue of the European Union (Withdrawal) Act 2018), the detailed breakdown of individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the share buyback programme is attached to this announcement

http://www.rns-pdf.londonstockexchange.com/rns/7718S_1-2024-6-17.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFSRRRIDLIS
Date   Source Headline
4th Jan 20235:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20235:00 pmRNSTotal Voting Rights
3rd Jan 20235:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20235:00 pmRNSBlock listing Interim Review
3rd Jan 20235:00 pmRNSDirector/PDMR Shareholding
22nd Dec 20225:00 pmRNSDirector/PDMR Shareholding
2nd Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSDirector/PDMR Shareholding
1st Dec 20225:00 pmRNSTotal Voting Rights
29th Nov 20221:50 pmRNSIFRS 17 investor and analyst event
18th Nov 20227:00 amRNSTrading Statement
11th Nov 20229:00 amRNSBoard Committee Appointment
7th Nov 20224:31 pmRNSHolding(s) in Company
2nd Nov 20225:00 pmRNSDirector/PDMR Shareholding
1st Nov 20225:33 pmRNSDirector/PDMR Shareholding
1st Nov 20225:31 pmRNSDirector/PDMR Shareholding
1st Nov 20225:30 pmRNSTotal Voting Rights
14th Oct 20229:00 amRNSBoard Committee Appointment
4th Oct 20225:00 pmRNSDirector/PDMR Shareholding
4th Oct 20227:00 amRNSTrading Statement
3rd Oct 20225:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:00 pmRNSTotal Voting Rights
3rd Oct 20225:00 pmRNSDirector/PDMR Shareholding
28th Sep 20225:00 pmRNSDirector/PDMR Shareholding
28th Sep 20225:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20225:00 pmRNSDirector/PDMR Shareholding
1st Sep 20225:00 pmRNSDirector/PDMR Shareholding
1st Sep 20225:00 pmRNSDirector/PDMR Shareholding
1st Sep 20225:00 pmRNSTotal Voting Rights
10th Aug 20225:00 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSL&G Half Year Results 2022 Part 3
9th Aug 20227:00 amRNSL&G Half Year Results 2022 Part 2
9th Aug 20227:00 amRNSL&G Half Year Results 2022 Part 1
2nd Aug 20225:00 pmRNSDirector/PDMR Shareholding
1st Aug 20225:00 pmRNSDirector/PDMR Shareholding
1st Aug 20225:00 pmRNSDirector/PDMR Shareholding
1st Aug 20225:00 pmRNSTotal Voting Rights
26th Jul 20229:00 amRNSBoard Committee Appointment
7th Jul 20227:00 amRNSTrading Statement
4th Jul 20225:00 pmRNSDirector/PDMR Shareholding
1st Jul 20225:00 pmRNSDirector/PDMR Shareholding
1st Jul 20225:00 pmRNSBlock listing Interim Review
1st Jul 20225:00 pmRNSDirector/PDMR Shareholding
1st Jul 20225:00 pmRNSTotal Voting Rights
28th Jun 20227:00 amRNSHolding(s) in Company
17th Jun 20227:00 amRNSDirectorate Change
15th Jun 20225:03 pmRNSDirector/PDMR Shareholding
7th Jun 20225:00 pmRNSDirector/PDMR Shareholding
7th Jun 20225:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.